Evidence map›Paper›PMID 42727090›Full record

ArticleInternational journal of epidemiology2026

Adiposity and infection-related mortality: Mendelian randomization study of 126 000 Mexican adults.

Lukman Lawal, Eirini Trichia, Jesus Alegre-Díaz, Paulina Baca, Elizabeth Barerra, Carlos González-Carballo, Raúl Ramirez-Reyes, Fernando Rivas, Diego Aguilar-Ramirez, Fiona Bragg and 13 more

Abstract read
In one paragraph

Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Lukman LawalClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Eirini TrichiaClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-7655-5905
Jesus Alegre-DíazExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Paulina BacaExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Elizabeth BarerraExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Carlos González-CarballoExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Raúl Ramirez-ReyesExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Fernando RivasExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Diego Aguilar-RamirezClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-2298-3768
Fiona BraggClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-9181-6886
William G HerringtonClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-1172-8243
Michael HillClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Tianshu LiuClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Michael TurnerClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Jason TorresClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-7537-7035
Alejandra Vergara-LopeClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Rachel WadeClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Rory CollinsClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-8288-8602
Pablo Kuri-MoralesInstituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico.
Jaime BerumenExperimental Research Unit from the Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0001-6707-3317
Jonathan R EmbersonClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-7792-9422
Roberto Tapia-ConyerFaculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0009-0000-8332-0189
Louisa Gnatiuc FriedrichsClinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Funding

Cancer Research UKHealth Data Science UK HDR-23007Medical Research CouncilMedical Research Council-Kidney Research UK Professor David Kerr Clinician Scientist MR/R007764/1Mexican Health MinistryNational Autonomous University of MexicoNational Council of Science and Technology for MexicoNational Institute of Health Research Oxford Biomedical Research Councilthe British Heart Foundation RE/13/1/30181UK Medical Research Council MC_UU_00017/2UK Medical Research Council MR/Z504543/1University of Oxford, Regeneron, and AstraZenecaWellcome TrustWellcome Trust 058299/Z/99Wellcome Trust Core Award 203141/Z/16/Z
6 · The paper itself

Abstract

backgroundThe causal relevance of different adiposity markers to infection-related death remains uncertain. We estimated the lifelong associations of genetically predicted adiposity traits with infection-related mortality among 126 491 Mexican adults.

methodsMendelian randomization (MR) using trans-ancestry instruments for body mass index (BMI), fat-mass percentage (FM%), and waist and hip circumference was used to estimate causal effects on infection-related mortality at ages 35-74 years, overall and across six infection subtypes. Multivariable MR was used to assess independent associations.

resultsGenetic instruments explained 1.6%-3.5% of the variance in adiposity markers and the strengths of their associations with the markers were similar in men and women. Over 20 years, 2592 infection-related deaths occurred at ages 35-74 years. Genetically predicted adiposity was strongly associated with infection mortality, with the strongest association for FM% [hazard ratio (HR) per 1-SD higher level: 2.54; 95% confidence interval (CI) 1.91-3.38] and the weakest for hip circumference (HR 1.61; 95% CI 1.30-2.01). Associations were consistent across six subtypes: respiratory; urinary tract; gastrointestinal; sepsis; skin, bone, and connective tissue; and other infections. For BMI and FM%, mutual adjustment for waist and hip circumference reduced the associations by nearly one-third. For waist circumference, adjustment for BMI and hip circumference reduced the association by more than half, while, for hip circumference, mutual adjustment for BMI and waist circumference almost eliminated its association. Sensitivity analyses supported the main conclusions.

conclusionHigher adiposity is causally associated with a higher risk of infection-related mortality in Mexican adults. Strategies to reduce the population levels of adiposity in Mexico could contribute to lowering mortality from infection.

Indexed as

AdiposityInfectionsObesityAdultAgedBody Mass IndexFemaleHumansMaleMendelian Randomization AnalysisMexicoMiddle AgedProportional Hazards ModelsRisk FactorsWaist CircumferenceadiposityinfectionMendelian randomizationMexico

Identifiers

PMID42727090
PMCPMC13568476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.